These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 238821
21. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat. Jorritsma J, Meerman JH, Vonk RJ, Mulder GJ. Xenobiotica; 1979 Apr; 9(4):247-52. PubMed ID: 483860 [Abstract] [Full Text] [Related]
22. Mirex-induced impairment of hepatobiliary function. Suppressed biliary excretion of imipramine and sulfobromophthalein. Mehendale HM. Drug Metab Dispos; 1977 Apr; 5(1):56-62. PubMed ID: 13976 [Abstract] [Full Text] [Related]
23. Uptake of ouabain by isolated hepatocytes from livers of developing rats. Stacey NH, Klaassen CD. J Pharmacol Exp Ther; 1979 Nov; 211(2):360-3. PubMed ID: 501566 [Abstract] [Full Text] [Related]
24. Hepatic uptake of foreign compounds: influence of acute extrahepatic biliary obstruction. Yam J, Roberts RJ. J Pharmacol Exp Ther; 1977 Feb; 200(2):425-33. PubMed ID: 839446 [Abstract] [Full Text] [Related]
25. The influence of dehydrocholate on hepatic uptake and biliary excretion of 3H-taurocholate and 3H-ouabain. Meijer DK, Vonk RJ, Scholtens EJ, Levine WG. Drug Metab Dispos; 1976 Feb; 4(1):1-7. PubMed ID: 3395 [Abstract] [Full Text] [Related]
26. [Plasma elimination, hepatic uptake and biliary excretion of tritiated cardiac glycosides by the isolated perfused liver]. Kolenda KD, Peters T, Seiler KU. Naunyn Schmiedebergs Arch Pharmakol; 1970 Feb; 266(4):375-6. PubMed ID: 4253810 [No Abstract] [Full Text] [Related]
27. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist. Imawaka H, Sugiyama Y. J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854 [Abstract] [Full Text] [Related]
30. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro. Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y. Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591 [Abstract] [Full Text] [Related]
32. Differences in liver weight, mortality in cerium-treated mice and 144Ce levels in blood, liver, urine and faeces at various intervals after treatment with nafenopin and pregnenolone 16-alpha-carbonitrile (PCN). Bjondahl K. Med Biol; 1976 Dec; 54(6):454-60. PubMed ID: 1004028 [Abstract] [Full Text] [Related]
33. Influence of phenobarbital pretreatment on biliary rose bengal excretion in rats. Gógl A, Ruzsa CS, Fischer E. Acta Physiol Acad Sci Hung; 1977 Dec; 49(3-4):201-8. PubMed ID: 755336 [Abstract] [Full Text] [Related]
34. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat. Koopen NR, Wolters H, Havinga R, Vonk RJ, Jansen PL, Müller M, Kuipers F. Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655 [Abstract] [Full Text] [Related]
35. The anion transport inhibitor DIDS activates a Ba2+-sensitive K+ flux associated with hepatic exocrine secretion. Hill CE. Can J Physiol Pharmacol; 1999 Apr; 77(4):268-75. PubMed ID: 10535675 [Abstract] [Full Text] [Related]
36. Hepatic uptake and biliary excretion of d-tubocurarine and trimethyltubocurarine in the rat in vivo and in isolated perfused rat livers. Meijer DK, Weitering JG, Vonk RJ. J Pharmacol Exp Ther; 1976 Jul; 198(1):229-39. PubMed ID: 933009 [Abstract] [Full Text] [Related]
37. Effects of the hypolipidemic drug nafenopin on the zona fasciculata of the rat adrenal cortex: a correlated biochemical and stereological study. Mazzocchi G, Robba C, Rebuffat P, Belloni AS, Nussdorfer GG. Anat Rec; 1982 Nov; 204(3):245-54. PubMed ID: 7158828 [Abstract] [Full Text] [Related]
38. Transcriptional and translational control of nafenopin-induced ornithine decarboxylase activity in rat liver. Lam DC, Levine WG. Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):113-22. PubMed ID: 7394309 [Abstract] [Full Text] [Related]
39. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats. Takikawa H, Sugiyama Y, Fernandez-Checa JC, Kuhlenkamp J, Ookhtens M, Kaplowitz N. Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188 [Abstract] [Full Text] [Related]
40. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response. Reddy JK, Azarnoff DL, Svoboda DJ, Prasad JD. J Cell Biol; 1974 May; 61(2):344-58. PubMed ID: 4208071 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]